Dyadic International (DYAI) Stock Price, Quote & News

Company Profile

Dyadic International, Inc., together with its subsidiaries, a biotechnology platform company, develops, manufactures, and commercializes proteins and enzymes in the United States. The company offers Dapibus Protein Production Platform, a proprietary expression system designed to produce non-animal proteins and enzymes for non-pharmaceutical markets, including life sciences, food and nutrition, and bio-industrial sector; and C1 Protein Production Platform, a thermophilic fungal platform for large...

Industry: Biotechnology

Sector: Healthcare

Phone: 561 743 8333

Fax: 561 743 8343

Website: www.dyadic.com

Address:

1044 North U.S. Highway One, Suite 201, Jupiter, United States

Audienceof1 Sep. 16 at 3:19 PM

$DYAI good God was I wrong !

0 · Reply

iAccess_Alpha Sep. 16 at 2:57 PM

$DYAI presentation replay is now available. Access the replay: https://www.webcaster5.com/Webcast/Page/3171/54486 #microcap #smallcap #investing

0 · Reply

iAccess_Alpha Sep. 15 at 12:22 PM

$DYAI presents today. September 15, 2026 | 12:00 PM ET Watch live via Stocktwits or register here: https://www.webcaster5.com/Webcast/Page/3171/54486 #microcap #smallcap #investing

0 · Reply

Jbaffs Sep. 15 at 2:26 AM

$DYAI these guys should not be a public company. They have literally no concept.

1 · Reply

KoalaFlipper Sep. 13 at 6:35 PM

$DYAI

0 · Reply

iAccess_Alpha Sep. 11 at 1:21 PM

$DYAI presents next week at iAccess Alpha's Virtual Best Ideas Fall Investment Conference. September 15, 2026 | 12:00 PM ET Register to watch live: https://www.webcaster5.com/Webcast/Page/3171/54486 #microcap #smallcap #investing

0 · Reply

KoalaFlipper Sep. 10 at 10:52 AM

$DYAI extremely oversold!! perfect time to buy! 🚀

1 · Reply

KoalaFlipper Sep. 9 at 10:05 AM

$DYAI maybe it goes back to 1.40+ looks like they doing well and there sales are increasing alot.

2 · Reply

MavrickPete Sep. 7 at 8:14 PM

$DYAI Q1 2026 revenue jumped 182% YoY to $1.1M...

1 · Reply

Arb_raccoon Sep. 3 at 4:20 PM

$DYAI the beatings will continue until morale improves

0 · Reply

Dyadic International Transcript: IAccess Alpha Virtual Best Ideas Fall Investment Conference 2026

2026-09-11T21:35:26.000Z - 5 days ago

Dyadic International files to sell 3.625M shares of common stock for holders

Sep 11, 2026, 8:00 AM EDT - 5 days ago

Dyadic International Registration statement: Registration filing

Aug 26, 2026, 3:00 PM EDT - 21 days ago

Dyadic International Transcript: Q3 Investor Summit Group Virtual Conference 2026

2026-08-17T07:52:00.000Z - 4 weeks ago

Dyadic International prices 3.625M shares at 79.5c in registered direct offering

Aug 13, 2026, 8:00 AM EDT - 4 weeks ago

Dyadic International, Inc. Secures $2.9 Million Through Registered Direct Offering and Concurrent Private Placement

Aug 12, 2026, 5:00 PM EDT - 5 weeks ago

Dyadic International Earnings Call Transcript: Q2 2026

Aug 12, 2026, 5:00 PM EDT - 5 weeks ago

Dyadic International Earnings release: Q2 2026

Aug 12, 2026, 5:00 PM EDT - 5 weeks ago

Dyadic International Quarterly report: Q2 2026

Aug 12, 2026, 8:30 AM EDT - 5 weeks ago

Dyadic Announces Second Quarter 2026 Financial Results Accelerating Commercialization Momentum Across Key Business Areas

2026-08-04T13:25:53.000Z - 6 weeks ago

Dyadic enters commercial license agreement with European biotechnology company

Aug 4, 2026, 7:25 AM EDT - 6 weeks ago

Dyadic Expands Commercial Non-Animal Dairy Pipeline Through New Strategic Development Agreement

Aug 3, 2026, 4:30 PM EDT - 6 weeks ago

Dyadic to Report Q2 2026 Financial Results and Host Conference Call on Wednesday August 12, 2026

Jul 28, 2026, 8:30 AM EDT - 7 weeks ago

Dyadic Develops Stable C1 Cell Lines and Produces Purified Scripps-Designed Bundibugyo Ebola Antigens from Plasmids in Approximately 15 Days

2026-07-24T11:45:16.000Z - 7 weeks ago

Dyadic International regains compliance with Nasdaq

Jul 24, 2026, 7:30 AM EDT - 7 weeks ago

Dyadic Announces Continued Listing on the Nasdaq Capital Market

2026-07-16T13:37:24.000Z - 2 months ago

Dyadic expands bio-industrial pipeline with new industrial enzyme program

Jul 16, 2026, 8:00 AM EDT - 2 months ago

Dyadic Expands Bio industrial Pipeline with New Proprietary Industrial Enzyme Program

Jul 7, 2026, 7:25 AM EDT - 2 months ago

Global Collaborations Continue to Validate Dyadic's C1 Platform and Expands Commercial Potential

Jun 30, 2026, 7:00 AM EDT - 2 months ago

Dyadic International Slides: Corporate presentation

2026-06-29T11:40:31.000Z - 2 months ago

Dyadic International allowed claims by Japan Patent Office

Jun 29, 2026, 7:25 AM EDT - 2 months ago

Dyadic Expands IP Protection and Business Development Activities in Japan

Jun 22, 2026, 8:46 AM EDT - 2 months ago

An Interview with the President & COO: How Dyadic is Commercializing Its Protein Platform Across Multi-Billion-Dollar Markets

Jun 18, 2026, 10:00 AM EDT - 3 months ago

Dyadic International Transcript: AGM 2026

Jun 18, 2026, 8:00 AM EDT - 3 months ago

Dyadic International Proxy statement: Proxy filing

Jun 15, 2026, 7:25 AM EDT - 3 months ago

Dyadic Highlights Accelerated Interest in C1 Biomanufacturing Platform Amid Ebola Preparedness Activities and Growing Commercial Adoption

May 28, 2026, 10:30 AM EDT - 3 months ago

Dyadic International Transcript: Lytham Partners Spring 2026 Investor Conference

2026-05-28T13:47:19.000Z - 3 months ago

Dyadic International, Scripps Research team to evaluate Hantavirus vaccine

May 28, 2026, 7:25 AM EDT - 3 months ago

Dyadic and Scripps Research Collaborate on Rapid-Response Hantavirus Antibody and Vaccine Development

May 21, 2026, 4:05 PM EDT - 3 months ago

Dyadic to Participate in the Lytham Partners Spring 2026 Investor Conference on May 28, 2026

May 21, 2026, 3:45 PM EDT - 3 months ago

Skyline Corporate Communications Group, LLC Announces Dyadic Applied BioSolutions to Deliver a Live Presentation at the Skyline Signature Series™ on Wednesday, May 27 at 12:00 PM ET

May 20, 2026, 10:00 AM EDT - 3 months ago

Dyadic International Transcript: Sidoti Micro-Cap Virtual Conference

May 19, 2026, 9:35 AM EDT - 4 months ago

Dyadic Applied BioSolutions Announces Participation in Sidoti Virtual Investor Conference

May 19, 2026, 7:00 AM EDT - 4 months ago

Dyadic International Slides: Investor presentation

May 13, 2026, 5:00 PM EDT - 4 months ago

Dyadic International Earnings Call Transcript: Q1 2026

May 13, 2026, 5:00 PM EDT - 4 months ago

Dyadic International Earnings release: Q1 2026

May 13, 2026, 5:00 PM EDT - 4 months ago

Dyadic International Quarterly report: Q1 2026

May 13, 2026, 4:05 PM EDT - 4 months ago

Dyadic Announces First Quarter 2026 Financial Results and Highlights Recent Company Progress

May 12, 2026, 8:00 AM EDT - 4 months ago

Dyadic International Proxy statement: Proxy filing

May 1, 2026, 5:11 PM EDT - 4 months ago

Dyadic International Slides

May 1, 2026, 8:00 AM EDT - 4 months ago

Dyadic International Proxy statement: Proxy filing

Apr 29, 2026, 4:05 PM EDT - 4 months ago

Dyadic to Report Q1 2026 Financial Results and Host Conference Call on Wednesday May 13, 2026

Mar 25, 2026, 5:00 PM EDT - 5 months ago

Dyadic International Earnings Call Transcript: Q4 2025

Mar 25, 2026, 5:00 PM EDT - 5 months ago

Dyadic International Earnings release: Q4 2025

Mar 25, 2026, 5:00 PM EDT - 5 months ago

Dyadic International Annual report: Q4 2025

Mar 25, 2026, 4:51 PM EDT - 5 months ago

Dyadic Announces 2025 Financial Results and Highlights Recent Company Progress

2026-03-16T11:36:49.000Z - 6 months ago

Dyadic International enter distribution partnership with IBT Bioservices

Mar 16, 2026, 7:20 AM EDT - 6 months ago

Dyadic Applied BioSolutions Announces Commercial Distribution Partnership with IBT Bioservices

Mar 12, 2026, 1:30 PM EDT - 6 months ago

Dyadic International Transcript: Life Sciences Virtual Investor Forum

Mar 11, 2026, 4:10 PM EDT - 6 months ago

Dyadic to Report 2025 Full Year Financial Results and Host Conference Call on Wednesday, March 25, 2026

2026-03-04T12:23:22.000Z - 6 months ago

Dyadic International, Fermbox Bio launch of RNase-Free

Mar 4, 2026, 7:20 AM EST - 6 months ago

Dyadic and Fermbox Bio Launch First Product Under Expanded Collaboration: Animal-Origin-Free Recombinant DNase I (RNase-Free)

2026-03-02T12:33:34.000Z - 6 months ago

Dyadic International, Inzymes announce planned 2026 commercialization

2026-03-02T12:29:56.000Z - 6 months ago

Dyadic International, Inzymes announce planned 2026 commercialization

Mar 2, 2026, 7:20 AM EST - 6 months ago

Dyadic Applied BioSolutions and Inzymes ApS Announce Planned 2026 Commercialization of Non-Animal Dairy Enzyme Following Achievement of Development Milestone

Feb 17, 2026, 7:25 AM EST - 7 months ago

Dyadic Applied BioSolutions and Proliant Health & Biologicals Announce Commercial Launch of Recombinant Human Albumin

2025-12-17T12:26:09.000Z - 9 months ago

Dyadic International, Fermbox Bio expand strategic collaboration

2025-12-15T12:25:44.000Z - 9 months ago

Dyadic International establishes commercial partnership with Opes

Dec 15, 2025, 7:20 AM EST - 9 months ago

Dyadic Applied BioSolutions Establishes Commercial Partnership to Accelerate Adoption of Dyadic's Recombinant Growth Factors and Media Proteins

Dec 9, 2025, 9:30 AM EST - 9 months ago

Dyadic International Transcript: IAccess Alpha Virtual MicroCap Conference

Dec 1, 2025, 7:25 AM EST - 9 months ago

Dyadic and BRIG BIO Sign Development & Commercialization Agreement to Bring Animal-Free Bovine Alpha-Lactalbumin to Global Nutrition Markets

2025-11-12T22:30:23.000Z - 10 months ago

Dyadic International reports Q3 EPS (6c), consensus (4c)

Nov 12, 2025, 5:00 PM EST - 10 months ago

Dyadic International Earnings Call Transcript: Q3 2025

Nov 12, 2025, 5:00 PM EST - 10 months ago

Dyadic International Earnings release: Q3 2025

Nov 12, 2025, 5:00 PM EST - 10 months ago

Dyadic International Quarterly report: Q3 2025

Nov 12, 2025, 4:05 PM EST - 10 months ago

Dyadic Announces Third Quarter 2025 Financial Results and Highlights Strategic Progress

2025-11-10T12:38:06.000Z - 10 months ago

Dyadic International, ERS Genomics announces CRISPR/Cas9 license

Oct 29, 2025, 7:25 AM EDT - 10 months ago

Dyadic to Report Third Quarter 2025 Financial Results on Wednesday, November 12, 2025

2025-10-23T10:10:55.000Z - 10 months ago

Dyadic International assumed with a Buy at H.C. Wainwright

2025-10-06T12:50:17.000Z - 11 months ago

Dyadic International announces achievement of milestone payments

Oct 6, 2025, 8:30 AM EDT - 11 months ago

Dyadic Applied BioSolutions Announces Milestone Achievements and Recent Company Developments

Sep 18, 2025, 9:15 AM EDT - 12 months ago

Dyadic International Transcript: Small-Cap Virtual Conference

2025-09-08T13:20:27.000Z - 1 year ago

Craig-Hallum bullish on Dyadic International, initiates with a Buy

Sep 4, 2025, 9:00 AM EDT - 1 year ago

Dyadic to Present at Investor Conferences and BPI East

Aug 13, 2025, 5:00 PM EDT - 1 year ago

Dyadic International Earnings Call Transcript: Q2 2025

Aug 13, 2025, 5:00 PM EDT - 1 year ago

Dyadic International Quarterly report: Q2 2025

Aug 13, 2025, 5:00 PM EDT - 1 year ago

Dyadic International Earnings release: Q2 2025

Aug 13, 2025, 4:01 PM EDT - 1 year ago

Dyadic Reports Second Quarter 2025 Financial Results and Highlights of Recent Company Progress

Aug 13, 2025, 4:00 PM EDT - 1 year ago

Dyadic International Slides: Investor Presentation

Aug 5, 2025, 4:11 PM EDT - 1 year ago

Dyadic to Report Second Quarter 2025 Financial Results on Wednesday, August 13, 2025

Jul 31, 2025, 8:47 AM EDT - 1 year ago

UPDATE: Dyadic International, Inc. Announces Pricing of Public Offering of 6,052,000 Shares of Common Stock

Jul 31, 2025, 7:30 AM EDT - 1 year ago

Dyadic International, Inc. Announces Pricing of Public Offering of 6,052,000 Shares of Common Stock

Jul 30, 2025, 4:02 PM EDT - 1 year ago

Dyadic International, Inc. Announces Proposed Public Offering of Common Stock

Jul 2, 2025, 4:00 PM EDT - 1 year ago

Dyadic International, Inc. Announces Strategic Rebrand to Dyadic Applied BioSolutions

Jun 2, 2025, 8:35 AM EDT - 1 year ago

Dyadic Announces Leadership Change as Part of Ongoing Strategic Shift to Focus on High Demand Ancillary Proteins for Life Sciences, Nutrition, and Industrial Applications

May 14, 2025, 5:00 PM EDT - 1 year ago

Dyadic International Earnings Call Transcript: Q1 2025

May 14, 2025, 5:00 PM EDT - 1 year ago

Dyadic International Quarterly report: Q1 2025

May 14, 2025, 5:00 PM EDT - 1 year ago

Dyadic International Earnings release: Q1 2025

May 1, 2025, 3:00 PM EDT - 1 year ago

Dyadic to Report First Quarter 2025 Financial Results on Wednesday, May 14, 2025

Apr 29, 2025, 8:00 AM EDT - 1 year ago

Dyadic International Proxy statement: Proxy Filing

Apr 29, 2025, 8:00 AM EDT - 1 year ago

Dyadic International Proxy statement: Proxy Filing

Apr 16, 2025, 2:00 PM EDT - 1 year ago

Dyadic to Present at World Vaccine Congress | Washington

Mar 26, 2025, 5:00 PM EDT - 1 year ago

Dyadic International Earnings Call Transcript: Q4 2024

Mar 26, 2025, 5:00 PM EDT - 1 year ago

Dyadic International Annual report: Q4 2024

Mar 26, 2025, 5:00 PM EDT - 1 year ago

Dyadic International Earnings release: Q4 2024

Mar 26, 2025, 4:05 PM EDT - 1 year ago

Dyadic Reports 2024 Year-End Financial Results and Business Updates

Mar 26, 2025, 8:00 AM EDT - 1 year ago

Dyadic International Registration statement: Registration Filing

Mar 12, 2025, 4:00 PM EDT - 1 year ago

Dyadic to Report 2024 Full Year Financial Results and Host Conference call on Wednesday, March 26, 2025

Mar 6, 2025, 8:30 AM EST - 1 year ago

Dyadic to Attend Multiple Industry Events in March

Jan 6, 2025, 8:30 AM EST - 1 year ago

Dyadic Provides Business Update; Dyadic to Attend the 43rd Annual J.P. Morgan Healthcare Conference

Nov 21, 2024, 8:30 AM EST - 1 year ago

Dyadic Receives $3 Million Grant to Develop Cost-Effective Monoclonal Antibodies for RSV and Malaria Using C1 Platform Technology

Nov 12, 2024, 5:00 PM EST - 1 year ago

Dyadic International Earnings Call Transcript: Q3 2024

Nov 12, 2024, 5:00 PM EST - 1 year ago

Dyadic International Earnings release: Q3 2024

Nov 12, 2024, 5:00 PM EST - 1 year ago

Dyadic International Quarterly report: Q3 2024

Nov 4, 2024, 4:30 PM EST - 1 year ago

Dyadic to Report Third Quarter 2024 Financial Results on Tuesday, November 12, 2024

Oct 9, 2024, 8:00 AM EDT - 1 year ago

Dyadic Expands Global Presence with Participation in Key Industry Events

Sep 23, 2024, 9:50 AM EDT - 1 year ago

Dyadic Provides Alternative Proteins Business Update and Announces Attendance at Bioprocess International Conference

Aug 13, 2024, 5:00 PM EDT - 2 years ago

Dyadic International Earnings Call Transcript: Q2 2024

Aug 13, 2024, 5:00 PM EDT - 2 years ago

Dyadic International Quarterly report: Q2 2024

Aug 13, 2024, 5:00 PM EDT - 2 years ago

Dyadic International Earnings release: Q2 2024

Jul 30, 2024, 4:00 PM EDT - 2 years ago

Dyadic to Report Second Quarter 2024 Financial Results on Tuesday, August 13, 2024

Jun 28, 2024, 8:30 AM EDT - 2 years ago

Dyadic International, Inc. and Proliant Health and Biologicals announce Recombinant Albumin Development and Commercialization Partnership

May 30, 2024, 4:30 PM EDT - 2 years ago

Dyadic to Attend Industry Events in June

May 14, 2024, 5:00 PM EDT - 2 years ago

Dyadic International Earnings Call Transcript: Q1 2024

May 14, 2024, 5:00 PM EDT - 2 years ago

Dyadic International Quarterly report: Q1 2024

May 14, 2024, 5:00 PM EDT - 2 years ago

Dyadic International Earnings release: Q1 2024

May 14, 2024, 4:00 PM EDT - 2 years ago

Dyadic Announces First Quarter 2024 Financial Results and Highlights Recent Company Progress

Audienceof1 Sep. 16 at 3:19 PM

$DYAI good God was I wrong !

0 · Reply

iAccess_Alpha Sep. 16 at 2:57 PM

$DYAI presentation replay is now available. Access the replay: https://www.webcaster5.com/Webcast/Page/3171/54486 #microcap #smallcap #investing

0 · Reply

iAccess_Alpha Sep. 15 at 12:22 PM

$DYAI presents today. September 15, 2026 | 12:00 PM ET Watch live via Stocktwits or register here: https://www.webcaster5.com/Webcast/Page/3171/54486 #microcap #smallcap #investing

0 · Reply

Jbaffs Sep. 15 at 2:26 AM

$DYAI these guys should not be a public company. They have literally no concept.

1 · Reply

KoalaFlipper Sep. 13 at 6:35 PM

$DYAI

0 · Reply

iAccess_Alpha Sep. 11 at 1:21 PM

0 · Reply

KoalaFlipper Sep. 10 at 10:52 AM

$DYAI extremely oversold!! perfect time to buy! 🚀

1 · Reply

KoalaFlipper Sep. 9 at 10:05 AM

$DYAI maybe it goes back to 1.40+ looks like they doing well and there sales are increasing alot.

2 · Reply

MavrickPete Sep. 7 at 8:14 PM

$DYAI Q1 2026 revenue jumped 182% YoY to $1.1M...

1 · Reply

Arb_raccoon Sep. 3 at 4:20 PM

$DYAI the beatings will continue until morale improves

0 · Reply

Arb_raccoon Aug. 31 at 2:16 PM

$DYAI whale is trying to get out…

0 · Reply

iAccess_Alpha Aug. 26 at 1:55 PM

$DYAI will present at iAccess Alpha's Virtual Best Ideas Fall Investment Conference. September 15, 2026 | 12:00 PM ET https://www.webcaster5.com/Webcast/Page/3171/54486 #microcap #smallcap #investing

0 · Reply

NetworkNewsWire Aug. 17 at 6:24 PM

MissionIRNewsBreaks – $DYAI Entered Agreements for $2.9 Million Registered Direct Offering and Private Placement https://ibn.fm/od7FJ

0 · Reply

Gandalf01 Aug. 15 at 11:46 PM

$DYAI wow this is a total scam get out while you can. Imo.

0 · Reply

ZacksSCR Aug. 14 at 9:06 PM

$DYAI Second Quarter Results https://buff.ly/FaviY81

0 · Reply

KUMO2026 Aug. 14 at 10:25 AM

$DYAI new warrants at .005c this is thd last cash grab for the insiders before this company folds BK or OTC Betting on BK

1 · Reply

Arb_raccoon Aug. 13 at 1:53 PM

$DYAI and more dilution….for a fucking biotech company spending five times more on administration than R&D.

0 · Reply

KUMO2026 Aug. 13 at 10:13 AM

$DYAI looks like BK is coming or delist to OTC when i call a short on a stock, you better listen and run fast

1 · Reply

Arb_raccoon Aug. 12 at 8:45 PM

$DYAI About to listen to these guys fumble around basic questions with a condescending tone...

0 · Reply

Arb_raccoon Aug. 12 at 2:05 PM

$DYAI Not a single dollar in license or milestone revenue. Grant revenue is done this year. This is literally management taking out salaries and riding headlines until investors are smart enough to realize they don't make any on-going revenue.

0 · Reply

focafoca99 Aug. 12 at 12:57 PM

$DYAI released its Q2 2026 results in a press release attached to the 8-K.

0 · Reply

StocktwitsEarnings Aug. 12 at 12:51 PM

$DYAI Q2 '26 Earnings Results & Recap • Reported GAAP EPS of -$0.06 • Reported revenue of $0.96M down -0.57% YoY

0 · Reply

Market Cap	17.14M
Revenue (ttm)	3.09M
Net Income (ttm)	-7.36M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-238.19%
Debt to Equity Ratio	0.00

Volume	539,800
Avg Vol	217,878
Day's Range	N/A - N/A
Shares Out	40.06M
Stochastic %K	26%
Beta	0.96
Analysts	Strong Sell
Price Target	$5.50